PRF Technologies Ltd (PRFX)

NASDAQ

$1.86

PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.

Website: https://www.painreform.com

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Target: $12 (+545.16%)

Market Cap

$1.12M

P/B Ratio

0.14

Beta (5Y)

1.30

Price Chart

Adjust inflation

Log

Valuation

Market Cap$1.12M

P/S70.01

P/B0.14

Profitability

Total Revenue (TTM)$17K

Gross Profit (TTM)-$53K

EBITDA-$5.11M

Operating Margin-16200%

EPS-$6.05

Growth & Risk

Beta (5Y)1.30

Sharpe Ratio-0.27